Vaccine approach extends life of metastatic prostate cancer patients
January 26th, 2010
No comments
Vaccine approach extends life of metastatic prostate cancer patients
In a newly published clinical trial, patients with metastatic prostate cancer who received a vaccine of harmless poxviruses engineered to spur an immune system attack on prostate tumor cells lived substantially longer than patients who received a placebo vaccine, researchers report.
Read more on Science Daily
Categories: Prostate Cancer Approach, Cancer, extends, life, metastatic, Patients, Prostate, Vaccine
Powered by FireStats